as 04-01-2025 2:34pm EST
Founded: | 2002 | Country: | United States |
Employees: | N/A | City: | FLORHAM PARK |
Market Cap: | N/A | IPO Year: | N/A |
Target Price: | $28.00 | AVG Volume (30 days): | 1.5M |
Analyst Decision: | Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.40 | EPS Growth: | N/A |
52 Week Low/High: | $0.22 - $4.15 | Next Earning Date: | 03-13-2025 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Longcor Jarrod | CLRB | Chief Operating Officer | Jan 10 '25 | Buy | $0.28 | 30,000 | $8,400.00 | 83,141 |
CLRB Breaking Stock News: Dive into CLRB Ticker-Specific Updates for Smart Investing
Zacks
14 days ago
GuruFocus.com
19 days ago
Thomson Reuters StreetEvents
19 days ago
GlobeNewswire
19 days ago
GlobeNewswire
21 days ago
GlobeNewswire
a month ago
GlobeNewswire
2 months ago
GlobeNewswire
3 months ago
The information presented on this page, "CLRB Cellectar Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.